Acute myeloid leukemia (AML) is a severe cancer of the blood and bone marrow, often fatal. The disease is driven by leukemic stem cells that resist treatment and can become active again after therapy. Researchers from the University of Geneva, University Hospital of Geneva, and Inserm have identified these stem cells’ critical genetic and metabolic […]
Continue reading Targeting leukemia stem cells on Tech Explorist.